Honeywell (HON) Q4 2024 Earnings Call Transcript

Honeywell announced a full separation into three stand-alone public companies—Automation, Aerospace and Advanced Materials—targeted for completion in the second half of 2026, tax-free to shareholders, with one-time separation costs of $1.5 billion to $2 billion. Q4 sales rose 2% organically, backlog hit a record $35.3 billion, and 2024 free cash flow was $4.9 billion, while 2025 guidance calls for $39.6 billion-$40.6 billion in sales, adjusted EPS of $10.10-$10.50, and more than $3 billion in buybacks. The outlook is tempered by muted short-cycle demand, Bombardier-related dilution, and a $400 million FX headwind, but management signaled margin expansion and strong long-term value creation from the restructuring.

Analysis

The market is likely to underappreciate how much optionality this separation creates before any legal split occurs. The key second-order effect is that HON is effectively converting a complex conglomerate into three capital-allocation stories, which should widen the pool of natural owners and reduce the “conglomerate discount,” but the value unlock will likely be uneven: Aerospace should re-rate first on visibility/backlog, while Automation may lag until short-cycle demand inflects.

The near-term issue is that management is deliberately keeping the 2025 guide conservative, which means the stock can rally on narrative without needing a demand recovery. That setup is good for a de-risking trade, but it also means downside can show up fast if orders soften further or if tariffs/FX hit reported numbers harder than expected. The biggest fundamental tell will be whether backlog converts without margin leakage; if not, the separation story becomes a financial engineering story rather than an operating one.

Bombardier is strategically important because it buys Honeywell a multi-year installed-base annuity in aviation electronics, but the accounting burden is front-loaded while the revenue lift is back-ended. That should depress reported quality of earnings in the next few quarters and may keep some investors anchored to 2025 margins instead of looking through to 2026–27, which creates a window to buy weakness. The contrarian view is that the market may be overestimating how quickly management can normalize stranded costs and underestimating the cash drag from ongoing M&A integration plus higher R&D.

Best risk/reward is probably not an outright chase after the headline; it is a staged entry on pullbacks with a catalyst map around separation milestones, Q1/Q2 order trends, and capital deployment discipline. If management executes, the rerating can continue for months; if short-cycle demand doesn’t recover, HON becomes a lower-beta industrial with a more visible sum-of-the-parts floor, which limits downside versus peers with weaker balance sheets.

Key Decisions for Investors

• Go long HON on 3-6 month pullbacks; use the separation catalyst as the primary driver, but require evidence of backlog conversion and margin stability before adding. Risk/reward improves if the stock de-rates on FX/tariff noise without a change in orders.
• Pair trade: long HON / short a more cyclical industrial with heavier short-cycle exposure (e.g., ETN or IR) for 6-12 months. HON has better balance-sheet optionality and corporate-action catalysts, while peers are more exposed to a real industrial slowdown.
• Buy HON call spreads 6-12 months out rather than stock if you want upside to the 2026 separation rerate with limited downside. This captures the valuation expansion while capping the risk that short-cycle recovery slips another quarter.
• Take profits tactically into any spike on separation headlines; the next leg requires operating proof, not just restructuring news. If Q1/Q2 orders or margins disappoint, expect a fast air pocket in the high-multiple Aerospace narrative.
• Monitor BBD.B.TO for sympathy upside only as a secondary trade; Honeywell’s award is larger, but BBD’s sensitivity to the Bombardier contract is more direct and should be more volatile over the next 12-24 months.